Summary:
«Brainomix recently took the decision to refocus on pharma partnerships and accelerate global market expansion. The funding will specifically be used to extrapolate new medical indications for AI-assisted biomarker imaging from the established stroke platform, initially for Interstitial Lung Disease (ILD) and cancer.»
«With ‘e-Stroke’, the Oxford-based specialist for biomarker imaging has developed a fully automated AI imaging solution for stroke assessment that serves two purposes: earlier diagnostics and better treatment decision-making.»
Article written by Anna Engberg. Photo by Brainomix
23|12|2021
Source:
Mobi Health News